Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

167
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
167

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proton FLASH preserves neurocognition across delivery techniques: implications for clinical translation in pediatric brain tumors.

bioRxiv : the preprint server for biology·2026
Same author

Executive summary of American Radium Society Appropriate Use Criteria for the treatment of locoregionally recurrent rectal cancer.

Cancer·2026
Same author

Automated Assessment of Nondosimetric Aspects of Prostate Radiation Therapy Treatment Quality in a Large Plan Database.

Advances in radiation oncology·2026
Same author

Outcomes of Radiotherapy With or Without Dose Escalation to Lymph Node Metastases Detected by PET PSMA or Conventional Imaging in Node-Positive Prostate Cancer: A Real-World Multicenter Propensity Score-Matched (PRIMENOD) Analysis.

Clinical nuclear medicine·2026
Same author

A phase 2 trial of burosumab for treatment of fibroblast growth factor-23-mediated hypophosphatemia in children and adults with fibrous dysplasia.

Bone research·2026
Same author

Particle Therapy Co-Operative Group Consensus Statement on Reirradiation With Proton Therapy for Prostate Cancer.

International journal of particle therapy·2026

Related Experiment Video

Updated: Sep 10, 2025

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.1K

ACR-ACNM-ARS-SNMMI Practice Parameter for the Performance of Therapy With Radium-223 Dichloride.

Esma A Akin1, Paul E Wallner2, Sindu Alexander3

  • 1Department of Radiology, The George Washington University Medical Center, Washington, DC.

American Journal of Clinical Oncology
|August 25, 2025
PubMed
Summary

This updated practice parameter provides guidance on radium-223 dichloride therapy for physicians. It covers its use in metastatic cancers, including prostate cancer, and addresses safety and quality control.

Keywords:
radium-223radium-223 practice parameterradium-223 therapy

More Related Videos

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.2K
Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases
11:03

Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases

Published on: May 29, 2017

10.1K

Related Experiment Videos

Last Updated: Sep 10, 2025

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.1K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.2K
Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases
11:03

Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases

Published on: May 29, 2017

10.1K

Area of Science:

  • Nuclear Medicine and Molecular Imaging
  • Radiation Oncology

Background:

  • The American College of Radiology (ACR) and affiliated societies have updated their 2019 practice parameter for radium-223 dichloride therapy.
  • This revision incorporates new research and applications for radium-223 therapy since its initial publication.

Purpose of the Study:

  • To provide an updated practice parameter for radium-223 dichloride therapy.
  • To guide physicians in the appropriate use of radium-223 dichloride for various metastatic cancer sites.

Main Methods:

  • Collaborative revision by the ACR, American College of Nuclear Medicine (ACNM), American Radium Society (ARS), and Society of Nuclear Medicine and Molecular Imaging (SNMMI).
  • Review of reports published since the 2019 initial practice parameter.
  • Adherence to the ACR's established process for developing practice parameters and technical standards.

Main Results:

  • Significant investigation into radium-223 dichloride for numerous metastatic cancer sites beyond hormone-resistant prostate cancer.
  • The updated parameter addresses physical properties, indications (current and investigative), personnel qualifications, treatment specifications, radiopharmaceutical use, radiation safety, and quality control.

Conclusions:

  • The updated practice parameter guides credentialed physicians in radium-223 dichloride therapy.
  • It encompasses all aspects of patient and radioisotope management, including current and emerging indications.